Latest Articles
Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women.
Relugolix is an oral gonadotropin-releasing hormone receptor antagonist that suppresses sex steroid hormones and is approved as monotherapy for prostate cancer and as a fixed-dose combination with estradiol/norethindrone for the …
Published: Feb. 1, 2025, midnight
The effect of chronic inflammation on female fertility.
Inflammation has key biological roles in the battle against pathogens, and additional key processes in development and tissue homeostasis. However, when inflammation becomes chronic it can become a serious medical …
Published: Feb. 1, 2025, midnight
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer - OncLive
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer OncLive
Published: Jan. 31, 2025, 8:48 p.m.
New endometrial cancer study highlights overlooked risk factors - Brunel University News
New endometrial cancer study highlights overlooked risk factors Brunel University News
Published: Jan. 31, 2025, 3:25 p.m.
Cervical cancer surge in India: Doctors advise women in 30s to start regular screening with pap smears and HP - Indiatimes.com
Cervical cancer surge in India: Doctors advise women in 30s to start regular screening with pap smears and HP Indiatimes.com
Published: Jan. 31, 2025, 11:07 a.m.
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer - OncLive
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer OncLive
Published: Jan. 30, 2025, 10:54 p.m.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive
Published: Jan. 30, 2025, 10:29 p.m.
Endometrial Cancer Market Size to Reach USD 31.2 Billion by 2035, Impelled by Increasing Rates of Obesity and Hormonal Imbalances - BioSpace
Endometrial Cancer Market Size to Reach USD 31.2 Billion by 2035, Impelled by Increasing Rates of Obesity and Hormonal Imbalances BioSpace
Published: Jan. 30, 2025, 5:37 p.m.
Your hormones could be fuelling cancer. Here's what every woman and man needs to know - Hindustan Times
Your hormones could be fuelling cancer. Here's what every woman and man needs to know Hindustan Times
Published: Jan. 30, 2025, 3:37 p.m.
‘I looked pregnant but it turned out to be cancer - doctors had to take everything’ - The Mirror
‘I looked pregnant but it turned out to be cancer - doctors had to take everything’ The Mirror
Published: Jan. 30, 2025, 4 a.m.
Link copied to clipboard!